Full Year 2023 Guidance
Revenue of at least $1,840 million
Consistent with prior practice, we are not providing guidance on net income at this time due to the volatility of certain required
Credit Suisse analyst A.J. Rice downgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Neutral to Underperform and lowers the price target from $2 to $1.
Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced that its Chief Executive Officer